Published in Oncotarget on April 13, 2017
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer (2008) 18.08
Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer (2005) 9.04
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods (2009) 9.00
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol (2009) 8.63
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell (2009) 8.33
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene (2005) 5.74
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene (2007) 4.90
The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res (2008) 4.04
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol (2012) 3.98
Asymmetric cell divisions promote Notch-dependent epidermal differentiation. Nature (2011) 3.64
Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell (2013) 3.61
Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J (2002) 3.30
Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev (2002) 3.22
Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res (2008) 2.67
The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J (2011) 2.29
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene (2010) 2.25
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell (2009) 2.00
Mouse germ line stem cells undergo rapid and stochastic turnover. Cell Stem Cell (2010) 1.97
EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell (2012) 1.94
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene (2012) 1.85
DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development (1998) 1.83
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer (2014) 1.70
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol (2010) 1.63
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med (2013) 1.59
Impairment of T cell development in deltaEF1 mutant mice. J Exp Med (1997) 1.56
Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis. Adv Exp Med Biol (2008) 1.45
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res (2011) 1.37
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol (2014) 1.35
miR-200b and miR-429 function in mouse ovulation and are essential for female fertility. Science (2013) 1.27
Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition. Mod Pathol (2011) 1.18
The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett (2013) 1.18
Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J Hepatol (2010) 1.16
Epigenetics and the plasticity of differentiation in normal and cancer stem cells. Oncogene (2006) 1.13
MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis. J Clin Invest (2014) 1.07
BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer (2007) 1.01
Organization of the gene encoding transcriptional repressor deltaEF1 and cross-species conservation of its domains. Gene (1996) 1.00
Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma. Oncogene (2010) 0.99
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun (2016) 0.90
ZEB1 in Pancreatic Cancer. Cancers (Basel) (2010) 0.86
The Numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells. J Cell Biol (2015) 0.85
Systematically labeling developmental stage-specific genes for the study of pancreatic β-cell differentiation from human embryonic stem cells. Cell Res (2014) 0.83
Role of p53 in the progression of gastric cancer. Oncotarget (2014) 0.82
Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer. Oncotarget (2016) 0.80
Control of stem cell self-renewal and differentiation by the heterochronic genes and the cellular asymmetry machinery in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2015) 0.77
Expression pattern of Ngn3 in dairy goat testis and its function in promoting meiosis by upregulating Stra8. Cell Prolif (2013) 0.76
ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer. PLoS One (2016) 0.76
Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models. Theranostics (2017) 0.75
ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer. Cell Death Dis (2017) 0.75
Sox2 Communicates With Tregs Through CCL1 To Promote The Stemness Property Of Breast Cancer Cells. Stem Cells (2017) 0.75
ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3. Oncotarget (2017) 0.75